Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460368 · ClinicalTrials.gov registry record · Phase 1
A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT01460368 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 67 participants.
The verdict
NCT01460368, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
Part A: The purpose of Part A of the study is to look at the electrocardiogram (ECG) effects due to blood sugar changes after a meal compared to when LY2409021 is also given with a meal. Part B: The purpose of Part B is to evaluate the effect of LY2409021, when given at a dose level much higher than what would normally be given, on the electrical activity of the heart as measured by ECG in relation to placebo and moxifloxacin.
Interventions
- DRUG Placebo
- DRUG Moxifloxacin
- DRUG LY2409021
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01460368
The ClinicalTrials.gov registry entry for NCT01460368 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01460368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01460368 about?
NCT01460368 is a clinical study titled "A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart". Part A: The purpose of Part A of the study is to look at the electrocardiogram (ECG) effects due to blood sugar changes after a meal compared to when LY2409021 is also given with a meal. Part B: The purpose of Part B is to evaluate the effect of LY2409021, when given at a dose level much higher tha...
What is the current status of trial NCT01460368?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2011-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01460368?
The interventions under investigation include: Placebo (DRUG), Moxifloxacin (DRUG), LY2409021 (DRUG).
Who is sponsoring clinical trial NCT01460368?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.